Experimental Leishmania (L.) amazonensis leishmaniasis: Characterization and immunogenicity of subcellular fractions

Immunological Investigations

Volumn 36, Issue 4, 2007, Pages 473-492

  Valle, T Zaverucha Do ^a   Gaspar, E B ^b   Souza Lemos, C ^a   Souza, C S F ^a   Márquez, F B Zamora ^a   Baetas Da Cruz, W ^a   D'Escofier, L N ^a   Corte Real S ^a   Calabrese, K S ^a   Da Costa, S C Gonçalves ^a,c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Instituto Oswaido Cruz   (Brazil)

Author keywords

BCG; Delayed type hypersensitivity; Leishmania (Leishmania) amazonesis; Murine model; Subcellular fractionation; Transmission electron microscopy

Indexed keywords

BCG VACCINE; CYCLOPHOSPHAMIDE;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FOOT PAD; HISTOPATHOLOGY; HYPERSENSITIVITY REACTION; IMMUNOGENICITY; LEISHMANIA; LEISHMANIASIS; LEUKOCYTE; MICROSOME; MICROTUBULE; MOUSE; NONHUMAN; PARASITE IDENTIFICATION; PRIORITY JOURNAL; SWELLING; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; FEMALE; LEISHMANIA; LEISHMANIASIS; MICE; PROTOZOAN VACCINES; SUBCELLULAR FRACTIONS;

EID: 34547919251     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130701360972     Document Type: Article

References (54)

1. Alexander, J. (1982). A radio attenuated Leishmania major vaccine markedly increases the resistance of CBA mice to subsequent infection with Leishmania mexicana mexicana. Trans. Roy. Soc. Trop. Med. Hyg. 76:646-649.
2. Andrade, Z., Andrade, S. G., and Sadigursky, M. (1987). Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide. Am. J. Pathol. 127(3), 467-473.
3. Angelopoulos, E. (1970). Pellicular microtubules in the family Trypanosomatidae. J. Protozool. 17:39-51.
4. Askenase, P. H., Hayden, B. J., Gershon, R. K. (1975). Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J. Exp. Med. 141(3), 697-702.
5. Bradford, M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye biding. Anal. Biochem. 72:248-254.
6. Calabrese, K. S. (1999). Immunosuppressive drugs as a tool to explore immunopathology in experimental Chagas disease. Mem. Inst. Oswaldo Cruz. Suppl. I:273-276.
7. Champsi, J. and McMahon-Pratt, D. (1988). Membrane glycoprotein M-2 protects against Leishmania amazonensis infection. Infect. Immun. 56:3272-3279.
8. de Souza, W. and da Cunha-e-Silva, N. L. (2003). Cell fractionation of parasitic protozoa: a review. Mem. Inst. Oswaldo Cruz. 98:151-170.
9. Dereure, J., Thanh, H. D., Lavabre-Bertrand, T., Cartron, G., Bastides, F., Richard-Lenoble, D., and Dedet, J. P. (2003). Visceral leishmaniasis. Persistence of parasites in lymph nodes after clinical cure. J. infect. 47:77-81.
10. Drummelsmith, J., Brochu, V., Girard, I., Messier, N., and Ouellette, M. (2003). Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms. Mol. Cell. Proteom. 2:146-155.
11. Dubuy, H. G., Mattern, C. F., and Riley, F. L. (1965). Isolation and characterization of DNA from kinetoplasts of Leishmania enriettii, Science 12:754-766.
12. Gazda, L. S., Baxter, A. G., and Lafferty, K. J. (1996). Regulation of autoimmune diabetes: characteristics of non-islet-antigen specific therapies. Immunol. Cell. Biol. 74:401-407.
13. Gonçalves Da Costa, S. C, Barbosa-Santos, E. G. O., and Lagrange, P. H. (1988). Vaccination of mice against Leishmania mexicana amazonensis with polysomal fraction associated with BCG. Ann. Immunol. (Institut Pasteur) 139:143-156.
14. Gonçalves Da Costa, S. C., and Lagrange, P. H. (1981). Development of cell mediated immunity to flagellar antigens and acquired resistance to infection by Trypanosoma cruzi in mice. Mem. Inst. Oswaldo Cruz 76:367-381.
15. Handman, E. (2001). Leishmaniasis: current status of vaccine development. Clin. Microbiol. Rev. 14:229-243.
16. Hermeto, M. V., Vieira-Dias, D., Genaro, O., da Costa, C. A., Toledo, V. P., Michalick, M. S., Tafuri, W. L., Chaves, K. M., and Mayrink, W. (1993). Delayed hypersensitivity skin-text using Leishvacin for epidemiological survey of canine cutaneous leischmaniasis in rural area of Minas Gerais state Brasil. Mem. Inst. Oswaldo Cruz 88:635-636.
17. Hodgkinson, V. H., Herman, R., and Semprevivo, L. (1980). Leishmania donovani correlation among assays of amasaigotes viability. Exp. Parasitol. 50:397-408.
18. Johnson, P., Neal, R. A., and Gall, D. (1963). Protective effect of killed trypanosome vaccines with incorporated adjuvants. Nature 5:200-283.
19. Khalil, E. A., El Hassan, A. M., Zijlstra, E. E., Mukhtar, M. M., Ghalib, H. W., Musa, B., Ibrahim, M. E., Kamil, A. A., Elsheikh, M., Babiker, A., and Modabber, F. (2000). Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan, Lancet 356:1565-1569.
20. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 15:227(5259):680-685.
21. Lagrange, P. H., Hurtrel, B., and Ravisse, P. (1978). La réaction locale granulomateuse après vaccination par le BCG chez la souris. 1.-Description. Ann. l'Inst. Pasteur. Immunol. 129C:529-546.
22. Lagrange, P. H., and Mackaness, G. B. (1974). A stable form of delayed-type hypersensitivity. J. Exp. Med. 141(1):82-96.
23. Lagrange, P. H., Mackness, G. B., and Miller, T. E. (1974). Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J. Exp. Med. 139:1529-1539.
24. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity. 6:541-549.
25. Locksley, R. M., Heinzel, F. P., Sadick, M. D., Holaday, B. J., and Gardner, K. D. Jr. (1987). Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets. Ann. l'Inst. Pasteur. Immunol. 138:744-749.
26. Mayrink, W., Williams, P., da Costa, C. A., Magalhaes, P. A., Melo, M. N., Dias, M., Oliveira Lima, A., Michalick, M. S., Ferreira Carvalho, E., and Barros, G. C. (1985). An experimental vaccine against American dermal leishmaniasis: experience in the State of Espirito Santo, Brazil. Ann. Trop. Med. Parasitol. 79:259-269.
27. McConville, M. J. and Ralton, J. E. (1997). Developmentally regulated changes in the cell surface architecture of Leishmania parasites. Behring Inst. Mitt. 99:34-43.
28. Mendonça, M. G., Brito, M. E. F., Rodrigues, E. H. G., Bandeira, V., Jardim, M. L., and Abath, F. G. C. (2004). Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J. Infect. Dis. 198:1018-1023.
29. Milon, G. and Marchal, G. (1978). Increased infiltration by monocytes in delayed type hypersensitivity site following cyclophosphamide treatment. Immunology 35:989-995.
30. Modabber, F. (1995). Vaccines against leishmaniasis. Ann. Trop. Med. Parasitol. 89:83-88.
31. Molano, I., Alonso, M. G., Miron, C., Redondo, E., Requena, J. M., Soto, M., Nieto, C. G., and Alonso, C. A. (2003). Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum. Vet. Immunol. Immunopathol. 20:92(1-2):1-13.
32. Mougneau, E., Altare, F., Wakil, A. E., Zheng, S., Coppola, T., Wang, Z. E., Waldmann, R., Locksley, R. M., and Glaichenhaus, N. (1995). Expression cloning of a protective Leishmania antigen. Science 268:563-566.
33. Nicolle, C. H. (1908). Culture du parasite du Bouton d'Orient. Compte Rendu Hebdomadaire des Séances de l'Académie des Sciences, Paris 146:842-843.
34. Oliveira, C. C. G., Lacerda, H. G., Maruns, D. R. M., Barbosa, J. D. A., Monteiro, G. R., Queiroz, J. W., Sousa, J. M. A., Ximenes, M. F. F. M., and Jeronimo, S. M. (2004). Changing epidemiology of American cutaneous leishmaniasis (ACL) in Brazil: a disease of the urban-rural interface. Acta Trop. 90:155-162.
35. Pereira, N. M., Timm, S. L., Gonçalves da Costa, S. C., Rebello, M. A., and De Souza, W. (1978). Trypanosoma cruzi: isolation and characterization of membrane and flagellar fractions. Exp. Parasitol. 46:225-234.
36. Piccinni, E. and Albergoni, V. (1973). ATPase activity in isolated flagella from Euglena gracilis. J. Protozool. 20:456-458.
37. Piras, M. M., de Rodriguez, O. O., and Piras, R. (1981). Trypanosoma cruzi: antigenic composition of axonemes and flagellar membranes of epimastigotes cultured in vitro. Exp. Parasitol. 51:59-73.
38. Requena, J. M., Alonso, C., Soto, M. (2000). Evolutionarily conserved proteins as prominent immunogens during Leishmania infections. Parasitol. Today 16(6):246-250.
39. Sadowski, P. D. and Steiner, J. W. (1968). Isolation of two distinct classes of polysomes from a nuclear fraction of rat liver. J. Cell. Biol. 37:147-162.
40. Salem, M. L., Kadima, A. N., EL-Naggar, S. A., Rubinstein M. P., Chen, Y., Gillanders, W. E., and Cole, D. J., (2007). Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells. J. Immunother. 30(1):40-53.
41. Schottelius, J. and Gonçalves da Costa, S. G. (1982). Studies on the relationship between lectin binding carbohydrates and different strains of Leishmania from the New World. Mem. Inst. Oswaldo Cruz. 77:19-27.
42. Schubach, A., Cuzzi-Maya, T., Oliveira, A. V., Sartori, A. Oliveira-Neto, M. P., Mattos, M. S., Araújo, M. L., Souza, W. J. S., Haddad, F., Perez, M. A., Pacheco, R. S., Momen, H., Coutinho, S. G., Marzochi, M. C. A., Belizia, K., Marzochi, F., and Gonçalves da Costa, S. C. (2001). Leishmanial antigens in the diagnosis of active lesions and ancient scars of American tegumentary leishmaniasis patients. Mem. Inst. Oswaldo Cruz. 96:987-996.
43. Schubach, A., Marzochi, M. C. A., Cuzzi-Maya, T., Oliveira, A. V., Araújo, M. L., Oliveira, A. L. C., Pacheco, R. S., Momen, H., Conceição-Silva, F., Coutinho, S. G., and Marzochi, K. B. F. (1998). Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. Am. J. Trop. Med. Hyg. 58:824-827.
44. Schuck, S., Honso, M., Ekross, K., Shevchenko, A., and Simons, K. (2003). Resistance of cell membranes to different detergents. Proc. Natl. Acad. Sci. USA 100:5795-5800.
45. Shehadeh, N., Calcinaro, F., Bradley, B. J., Bruchlim, I., Vardi, P., and Lafferty, K. J. (1994). Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 343:706-707.
46. Silva, J. S. and Rossi, M. A. (1990). Intensification of acute Trypanosoma cruzi myocarditis in Balb/mice pretreated with low doses of cyclophosphamide or gamma irradiation. Int. J. Exp. Pathol. 71:33-39.
47. Skeiky, Y. A., Kennedy, M., Kaufman, D., Borges, M. M., Guderian, J. A., Scholler, J. K., Ovendale, P. J., Picha, K. S., Morrissey, P. J., Grabstein, K. H., Campos-Neto, A., and Reed, S. G. (1998). LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile, J. Immunol. 161:6171-6179.
48. Smrkovski, L. L., and Larson, C. L. (1977). Effect of treatment with BCG on the course of visceral leishmaniasis in BALB/c mice. Infect. Immun. 18:561-562.
49. Taswell, C. (1981). Limiting dilution assays for the determination of immunocompetent cell frequencies, I. Data analysis. J. Immunol. 126:1614-1622.
50. Titus, R. G., Gueiros-Filho, F. J., De Freitas, L. A., and Beverley, S. M. (1995). Development of a safe live Leishmania vaccine line by gene replacement. Proc. Natl. Acad. Sci. USA 92:10267-10271.
51. Titus, R. G., Marchand, M., Boon. T., and Louis, J. A. (1985). A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7:545-555.
52. Turk, J. L., Parker, D., and Poulter, L. W. (1972). Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide. Immunology 23:493.
53. World Health Organization. 2000. Fact Sheet 116: WHO, Geneva.
54. Wrightsman, R. A., Miller, M. J., Saborio, J. L., and Manning, J. E. (1995). Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection. Infect. Immun. 63:122-125.